Product Information
AMOX-CLAV 250-62.5 MG/5 ML SUS is a generic product labeled by Cipla USA Inc., priced at $0.3920 per ML under NDC 69097009808. Its NADAC has been published 82 times since Mar 12, 2025.
FDA first approved this application on Nov 25, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250; 62.5 mg/5mL; mg/5mL
Manufacturer
Cipla USA Inc.NDC
69097009808
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMOXICILLIN; CLAVULANATE POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA065431FDA Approved
11/25/2008
TE Code
AB
On Market Since
10/28/2024
Pharmacological Classes
Price Statistics
The NADAC for AMOX-CLAV 250-62.5 MG/5 ML SUS has been published 82 times since Mar 12, 2025, and over the history we have for it it has declined 11.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3920 per ML |
|---|---|
| All-time high | $0.4571 (Dec 10, 2025) |
| All-time low | $0.3773 (Mar 18, 2026) |
| 52-week high | $0.4571 |
| 52-week low | $0.3773 |
| Median price | $0.4093 |
| Average price | $0.4125 |
| Largest weekly change | -12.5% (Feb 18, 2026) |
| Weeks tracked | 82 |
| Tracking since | Mar 12, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amoxicillin and Clavulanate Potassium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Penicillin-class Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMOX-CLAV 250-62.5 MG/5 ML SUS?
The current National Average Drug Acquisition Cost (NADAC) for AMOX-CLAV 250-62.5 MG/5 ML SUS, manufactured by Cipla USA Inc., is $0.3920 per ML (NDC 69097009808), effective Sep 30, 2026.
How has the price of AMOX-CLAV 250-62.5 MG/5 ML SUS changed over time?
Over the history we have for it, the NADAC for AMOX-CLAV 250-62.5 MG/5 ML SUS has declined 11.9%. It has been tracked across 82 weekly CMS publications since Mar 12, 2025.
What are the highest and lowest recorded NADAC prices for AMOX-CLAV 250-62.5 MG/5 ML SUS?
Since Mar 12, 2025, the NADAC for AMOX-CLAV 250-62.5 MG/5 ML SUS has ranged from a low of $0.3773 (Mar 18, 2026) to a high of $0.4571 (Dec 10, 2025), with a median of $0.4093 per ML.
Are there cheaper alternatives to AMOX-CLAV 250-62.5 MG/5 ML SUS?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMOX-CLAV 250-62.5 MG/5 ML SUS in a comparable dosage form, but none are currently priced below it.
Who manufactures AMOX-CLAV 250-62.5 MG/5 ML SUS?
AMOX-CLAV 250-62.5 MG/5 ML SUS (NDC 69097009808) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.